Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Third, monitoring burden where more compounds mean more lab markers to track and more potential variables if something changes
The application is supported by the Phase 2 HOPE-2 trial and its open-label extension alongside HOPE-3, which met both its primary and secondary endpoints when reported in December 2025
Estas cookies nos permiten contar las visitas y fuentes de circulacin para poder medir y mejorar el desempeo de nuestro sitio
Ophthalmic Vis
US$ 24.74
US$ 23.91
US$ 21.65
US$ 28.86
US$ 27.83
US$ 23.61
